title: Synergism between factor XII -4C>T and factor XIII Val34Leu polymorphisms in fibrinolytic therapy in acute myocardial infarction.
authors.forename: Diana
authors.initials: D
authors.lastname: Hernández-Romero
authors.forename: Francisco
authors.initials: F
authors.lastname: Marín
authors.forename: Kaeng W
authors.initials: KW
authors.lastname: Lee
authors.forename: Vanessa
authors.initials: V
authors.lastname: Roldán
authors.forename: Juan
authors.initials: J
authors.lastname: Caturla
authors.forename: Javier
authors.initials: J
authors.lastname: Corral
authors.forename: Mariano
authors.initials: M
authors.lastname: Valdés
authors.forename: Gregory Y H
authors.initials: GY
authors.lastname: Lip
authors.forename: Vicente
authors.initials: V
authors.lastname: Vicente
authors.forename: Rocío
authors.initials: R
authors.lastname: González-Conejero
mesh_terms: D000368:Aged; D016009:Chi-Square Distribution; D005174:Factor XII / Q000235:genetics*; D005176:Factor XIII / Q000235:genetics*; D005260:Female; D005838:Genotype; D006801:Humans; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood / Q000188:drug therapy* / Q000235:genetics*; D016017:Odds Ratio; D010641:Phenotype; D011110:Polymorphism, Genetic; D011446:Prospective Studies; D018570:Risk Assessment; D012307:Risk Factors; D013030:Spain; D015912:Thrombolytic Therapy; D016896:Treatment Outcome
chemical_list: D005174:Factor XII; D005176:Factor XIII